BX Swiss TOP 30 CHF
1.288,80
PKT
-5,60
PKT
-0,43
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.07.25 | Nestlé Sector Perform | RBC Capital Markets | |
| 24.07.25 | Nestlé Add | Baader Bank | |
| 24.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.07.25 | Nestlé Hold | Deutsche Bank AG | |
| 24.07.25 | Nestlé Sector Perform | RBC Capital Markets | |
| 24.07.25 | Roche Buy | UBS AG | |
| 24.07.25 | Roche Hold | Jefferies & Company Inc. | |
| 24.07.25 | Nestlé Neutral | UBS AG | |
| 24.07.25 | Roche Outperform | Bernstein Research | |
| 24.07.25 | Nestlé Market-Perform | Bernstein Research | |
| 24.07.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 24.07.25 | Nestlé Underperform | Jefferies & Company Inc. | |
| 23.07.25 | Givaudan Halten | DZ BANK | |
| 23.07.25 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 23.07.25 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.07.25 | Givaudan Hold | Deutsche Bank AG | |
| 23.07.25 | Roche Sell | Deutsche Bank AG | |
| 23.07.25 | Richemont Hold | Deutsche Bank AG | |
| 23.07.25 | Givaudan Neutral | UBS AG | |
| 23.07.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 23.07.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 23.07.25 | Givaudan Equal Weight | Barclays Capital | |
| 22.07.25 | Givaudan Add | Baader Bank | |
| 22.07.25 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.07.25 | Givaudan Neutral | UBS AG | |
| 22.07.25 | Roche Sell | Deutsche Bank AG | |
| 22.07.25 | Givaudan Underperform | Jefferies & Company Inc. | |
| 22.07.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 22.07.25 | Novartis Neutral | UBS AG | |
| 21.07.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 21.07.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 21.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 21.07.25 | Richemont Sector Perform | RBC Capital Markets | |
| 21.07.25 | Nestlé Equal Weight | Barclays Capital | |
| 21.07.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 21.07.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 18.07.25 | Novartis Kaufen | DZ BANK | |
| 18.07.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 18.07.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 18.07.25 | ABB (Asea Brown Boveri) Underweight | Barclays Capital |